ES2195370T3 - Procedimiento para la preparacion de 2`-fluoro-5-metil-beta-l-arabinofuranosiluridina. - Google Patents

Procedimiento para la preparacion de 2`-fluoro-5-metil-beta-l-arabinofuranosiluridina.

Info

Publication number
ES2195370T3
ES2195370T3 ES98939087T ES98939087T ES2195370T3 ES 2195370 T3 ES2195370 T3 ES 2195370T3 ES 98939087 T ES98939087 T ES 98939087T ES 98939087 T ES98939087 T ES 98939087T ES 2195370 T3 ES2195370 T3 ES 2195370T3
Authority
ES
Spain
Prior art keywords
fluoro
methyl
arabinofuranosiluridine
beta
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98939087T
Other languages
English (en)
Inventor
Chung K Chu
Yong S Choi
Jinfa Du
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Georgia Research Foundation Inc UGARF
Original Assignee
University of Georgia Research Foundation Inc UGARF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Georgia Research Foundation Inc UGARF filed Critical University of Georgia Research Foundation Inc UGARF
Application granted granted Critical
Publication of ES2195370T3 publication Critical patent/ES2195370T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/02—Monosaccharides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere a un procedimiento nuevo y mejorado que permite preparar 2''-fluoro-5-metil-{be}-L-arabinofuranosiluridina representada por la fórmula (1) que presenta una actividad antiviral, más específicamente una potente actividad antiviral contra el virus de la hepatitis B y el virus Epstein-Barr.
ES98939087T 1997-07-23 1998-07-23 Procedimiento para la preparacion de 2`-fluoro-5-metil-beta-l-arabinofuranosiluridina. Expired - Lifetime ES2195370T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5348897P 1997-07-23 1997-07-23

Publications (1)

Publication Number Publication Date
ES2195370T3 true ES2195370T3 (es) 2003-12-01

Family

ID=21984622

Family Applications (2)

Application Number Title Priority Date Filing Date
ES98939087T Expired - Lifetime ES2195370T3 (es) 1997-07-23 1998-07-23 Procedimiento para la preparacion de 2`-fluoro-5-metil-beta-l-arabinofuranosiluridina.
ES03075945T Expired - Lifetime ES2249678T3 (es) 1997-07-23 1998-07-23 Procedimiento de preparacion de l-ribosa.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES03075945T Expired - Lifetime ES2249678T3 (es) 1997-07-23 1998-07-23 Procedimiento de preparacion de l-ribosa.

Country Status (21)

Country Link
US (2) US6512107B2 (es)
EP (2) EP1327637B1 (es)
KR (1) KR100247505B1 (es)
CN (1) CN1113892C (es)
AR (1) AR009092A1 (es)
AT (2) ATE304547T1 (es)
AU (1) AU8758298A (es)
BR (1) BR9810804B1 (es)
DE (2) DE69831619T2 (es)
DK (1) DK1327637T3 (es)
ES (2) ES2195370T3 (es)
ID (1) ID20624A (es)
IL (1) IL121730A (es)
IN (1) IN186807B (es)
MY (1) MY117314A (es)
PT (2) PT1327637E (es)
SA (1) SA98180771B1 (es)
SI (1) SI1327637T1 (es)
TR (1) TR199701051A2 (es)
TW (1) TW434252B (es)
WO (2) WO1999005157A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW434252B (en) 1997-07-23 2001-05-16 Univ Georgia Res Found Process for the preparation of 2'-fluoro-5-methyl-β-L-arabino-furanosyluridine
KR100449618B1 (ko) * 1998-03-27 2004-11-16 부광약품 주식회사 2'-플루오로-5-메틸-β-L-아라비노푸라노실유리딘의 제조방법
US6462191B1 (en) * 2000-07-13 2002-10-08 Air Products And Chemicals, Inc. Synthesis of 2-deoxy-2-fluoro-arabinose derivatives
EP1373288B1 (en) * 2001-03-30 2005-06-29 Gilead Sciences, Inc. Process for the preparation of 2'-halo-beta-l-arabinofuranosyl nucleosides
KR100487992B1 (ko) * 2001-10-25 2005-05-09 부광약품 주식회사 2'-플루오로-5-메틸-β-엘-아라비노푸라노실유리딘의 황유도체
JP4651942B2 (ja) * 2001-12-20 2011-03-16 フアーマセツト・インコーポレイテッド Ｅｂｖ及びｋｈｓｖ感染並びにそれに伴う異常細胞増殖の治療
KR100976778B1 (ko) 2003-04-17 2010-08-18 부광약품 주식회사 1-（2'-플루오로-베타-엘-아라비노푸라노실）티민의 황 유도체를 유효 활성 성분으로 하는 b형 간염 바이러스 치료제
WO2006031725A2 (en) 2004-09-14 2006-03-23 Pharmasset, Inc. Preparation of 2'­fluoro-2'- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
KR101298631B1 (ko) 2005-06-07 2013-08-30 예일 유니버시티 엘에프엠에이유 및 엘디티를 사용하여 암 및 다른 증상또는 질환을 치료하는 방법
EP2159224B1 (en) 2007-06-18 2012-08-01 Sunshine Lake Pharma Co., Ltd Bromo-phenyl substituted thiazolyl dihydropyrimidines
GB0907551D0 (en) 2009-05-01 2009-06-10 Univ Dundee Treatment or prophylaxis of proliferative conditions
BR112020015745A2 (pt) 2018-02-02 2020-12-08 Maverix Oncology, Inc. Conjugados de fármacos de moléculas pequenas de monofosfato de gemcitabina
CN109320564B (zh) * 2018-10-26 2022-05-31 浙江晟格生物科技有限公司 一种l-来苏糖的制备工艺
CN109467583A (zh) * 2018-11-17 2019-03-15 扬州工业职业技术学院 一种克拉夫定的绿色合成工艺
CN109467541A (zh) * 2018-11-17 2019-03-15 扬州工业职业技术学院 一种绿色合成克拉夫定药物中间体的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3714473A1 (de) * 1987-04-30 1988-11-10 Basf Ag Kontinuierliches verfahren zur epimerisierung von zuckern, insbesondere von d-arabinose zu d-ribose
WO1989007602A1 (en) 1988-02-09 1989-08-24 Allied-Signal Inc. Solid catalysts for continuous interconversion of epimeric aldoses and aldose analogs
DE4002727A1 (de) * 1990-01-31 1991-08-01 Bayer Ag Mischungen aus waessrigen polymerdispersionen
US5587362A (en) 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
US5808040A (en) 1995-01-30 1998-09-15 Yale University L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides
TW434252B (en) 1997-07-23 2001-05-16 Univ Georgia Res Found Process for the preparation of 2'-fluoro-5-methyl-β-L-arabino-furanosyluridine

Also Published As

Publication number Publication date
SA98180771B1 (ar) 2006-10-29
EP1327637A1 (en) 2003-07-16
AR009092A1 (es) 2000-03-08
US20030139593A1 (en) 2003-07-24
TW434252B (en) 2001-05-16
IL121730A (en) 2005-03-20
TR199701051A3 (tr) 1999-03-22
IN186807B (es) 2001-11-10
US6512107B2 (en) 2003-01-28
SI1327637T1 (sl) 2005-12-31
WO1999005158A1 (en) 1999-02-04
ES2249678T3 (es) 2006-04-01
EP0998482B1 (en) 2003-04-02
PT1327637E (pt) 2005-11-30
EP1327637B1 (en) 2005-09-14
US20020062018A1 (en) 2002-05-23
BR9810804A (pt) 2000-09-12
BR9810804B1 (pt) 2012-01-10
US6894159B2 (en) 2005-05-17
KR19990013297A (ko) 1999-02-25
KR100247505B1 (ko) 2000-03-15
ATE304547T1 (de) 2005-09-15
DK1327637T3 (da) 2006-01-16
AU8758298A (en) 1999-02-16
DE69812959D1 (de) 2003-05-08
DE69831619T2 (de) 2006-06-14
CN1206012A (zh) 1999-01-27
MY117314A (en) 2004-06-30
DE69812959T2 (de) 2004-03-04
ID20624A (id) 1999-01-28
CN1113892C (zh) 2003-07-09
ATE236187T1 (de) 2003-04-15
DE69831619D1 (de) 2005-10-20
IL121730A0 (en) 1998-02-22
WO1999005157A1 (en) 1999-02-04
PT998482E (pt) 2003-08-29
EP0998482A1 (en) 2000-05-10
TR199701051A2 (xx) 1999-03-22

Similar Documents

Publication Publication Date Title
ES2195370T3 (es) Procedimiento para la preparacion de 2`-fluoro-5-metil-beta-l-arabinofuranosiluridina.
YU31000A (sh) Sferoidi, postupak za dobijanje i farmaceutske kompozicije
BR9812837A (pt) Processo para fazer um composto, e, composto
LT2003017A (en) Polymorphs of an epothilone analog
DK1200418T3 (da) Nematodicide trifluorbutener
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
GB0011203D0 (en) Chemical compounds
UY27552A1 (es) 17a- alquil- 17b- oxi-estratrienos y productos intermediarios para su preparacinn, uso de los 17a-alquil-17b-oxi-estratrienos para obtener medicamentos y preparados farmacéuticos.
MX9603050A (es) Derivados de la 1-h-3-aril-pirrolidin-2,4-diona como agentes pesticidas.
BRPI9917739B8 (pt) composto intermediário na preparação de inibidores de cox-2
UY26495A1 (es) " derivados de tiazolilamida"
IL160045A0 (en) Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
ES2187261B2 (es) Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos.
EA200400455A1 (ru) Способ приготовления быстрорастворимой дозировочной формы
BR0111729A (pt) 1-aril-4-oxo-1,4-dihidro-3-quinolinacarboxamidas como agentes antivirais
YU63696A (sh) Novi fenilamidin-derivati, postupci za njihovo pripremanje i njihova primena kao lekova
BR9808923A (pt) Composto, e, processo para fazer o mesmo
NO20016151L (no) Fremstilling av substituerte piperidin-4-oner
SE9904128D0 (sv) Novel compounds
BR9807785A (pt) Processo para a preparação do composto, e, composto
ID27733A (id) Metoksiminofenilasetamida
BR9607850A (pt) Processo para a preparação de um composto e composto
BR0011559A (pt) Processo para a preparação de derivados de 10, 11-metano benzossuberano
DK0685235T3 (da) Ekstrakter af Piliostigma thonningii, anvendelse heraf og formuleringer, som indeholder dem
IT1300056B1 (it) Eterocicli con anello a 6 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmaci